Czech PM's drug price cut plan faces trade complexity, industry warns

Czech PM Andrej Babiš proposes lowering medicine prices, but industry executive David Kolář warns the issue is complex and impacts international trade. The plan could face resistance from pharmaceutical firms and trade partners, with potential implications for drug availability and pricing dynamics in the Czech market.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works